Despite decades of basic and clinical research, thrombosis, a consequence of perturbed hemostasis, remains the major cause of morbidity and mortality in the United States. The topic of this Program Project, currently in its twenty-fifth year, is the regulation of the hemostatic process. Regulated hemostasis insures that following vascular trauma, hemorrhage is rapidly quenched, but at the same time, the fluidity of the blood is maintained. It is clear that both hemostasis and thrombosis are dynamic processes, characterized by the sequential accumulation and removal of newly activated platelets and fibrin at sites of vascular damage. The overall goal of this Program Project is to discover ways in which the dynamic nature of hemostasis and thrombosis can be interrupted for therapeutic benefit. Because of the interests and expertise of the participants in the Program, its projects are focused primarily on platelets. The projects will address the remarkably rapid activation of quiescent platelets, the dynamic nature of platelet plugs, and the use of platelets for targeted drug delivery. The Program Project consists of four projects and one core unit, all based at the University of Pennsylvania. The goals of Project 1 entitled """"""""Controlling allbps Function by Altering Its Energy Landscape,"""""""" are to gain a thermodynamic understanding of allbps regulation and to use this understanding to develop novel allosteric modulators that attenuate allbpS function. Project 2, entitled """"""""Platelet-Targeted Pro-Urokinase for Thrombolysis,"""""""" will continue the development of PLT/uPA-T, focusing on its use in the treatment of deep venous thrombosis. PLT/uPA-T is designed to target nascent thrombi while sparing stable mature clots by tethering thrombin-activatab;e urokinase to platelets using single-chain variable region fragments (scFv) of anti-allbps monoclonal antibodies. Project 3, new to the Program Project, is entitled """"""""Phosphatidylinositol Transfer Proteins &Platelet Biology"""""""" and addresses the role of Class I phosphatidylinositol transfer proteins in the synthesis of phosphoinositides by platelets. This is a novel topic not previously studied in the context of hemostasis and thrombosis. Project 4, entitled """"""""Subcellular Mechanisms of Platelet Activation,"""""""" will extend an ongoing project, merging new hypotheses about the platelet signaling network with new models of platelet activation in vivo. Studies will examine the structure of platelet thrombi by testing ideas about the development and contribution of a hierarchical thrombus structure, will consider how the platelet signaling network affects thrombus structure, and will study contact-dependent events arising from molecules present in the junctions between aggregating platelets. The four projects are supported by a single core unit that provides for the common administrative needs of the program.

Public Health Relevance

Heart attack and stroke remain among the leading causes of morbidity and mortality in the United States. The formation of platelet thrombi at sites of vascular damage, such as that caused by atherosclerosis, is the usual precipitating event for both of these processes. The goal of this Program Project has been, and remains, to understand how platelet function is regulated in order to devise more efficacious and safer ways to attenuate platelet accumulation sites at vascular damage, preventing subsequent tissue ischemia.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL040387-26A1
Application #
8668266
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Link, Rebecca P
Project Start
1994-06-15
Project End
2019-04-30
Budget Start
2014-05-16
Budget End
2015-04-30
Support Year
26
Fiscal Year
2014
Total Cost
$2,247,186
Indirect Cost
$675,182
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Greineder, Colin F; Johnston, Ian H; Villa, Carlos H et al. (2017) ICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic model. Blood Adv 1:1452-1465
Tomaiuolo, Maurizio; Brass, Lawrence F; Stalker, Timothy J (2017) Regulation of Platelet Activation and Coagulation and Its Role in Vascular Injury and Arterial Thrombosis. Interv Cardiol Clin 6:1-12
Zhao, Liang; Thorsheim, Chelsea L; Suzuki, Aae et al. (2017) Phosphatidylinositol transfer protein-? in platelets is inconsequential for thrombosis yet is utilized for tumor metastasis. Nat Commun 8:1216
Shen, Jian; Sampietro, Sara; Wu, Jie et al. (2017) Coordination of platelet agonist signaling during the hemostatic response in vivo. Blood Adv 1:2767-2775
Kononova, Olga; Litvinov, Rustem I; Blokhin, Dmitry S et al. (2017) Mechanistic Basis for the Binding of RGD- and AGDV-Peptides to the Platelet Integrin ?IIb?3. Biochemistry 56:1932-1942
Höök, Peter; Litvinov, Rustem I; Kim, Oleg V et al. (2017) Strong Binding of Platelet Integrin ?IIb?3 to Fibrin Clots: Potential Target to Destabilize Thrombi. Sci Rep 7:13001
Welsh, J D; Poventud-Fuentes, I; Sampietro, S et al. (2017) Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature. J Thromb Haemost 15:526-537
Cuker, Adam; Husseinzadeh, Holleh; Lebedeva, Tatiana et al. (2016) Rapid Evaluation of Platelet Function With T2 Magnetic Resonance. Am J Clin Pathol 146:681-693
Bennett, Joel S (2016) Shedding New Light on the Platelet Storage Lesion. Arterioscler Thromb Vasc Biol 36:1715-6
Zhu, S; Welsh, J D; Brass, L F et al. (2016) Platelet-targeting thiol reduction sensor detects thiol isomerase activity on activated platelets in mouse and human blood under flow. J Thromb Haemost 14:1070-81

Showing the most recent 10 out of 280 publications